Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Fumero

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Immune modulators and treatment interruptionFelipe García, Emilio Fumero, José María Gatell
The Journal of Antimicrobial Chemotherapy|February 14, 2004
Immunosuppressive drugs as an adjuvant to HIV treatmentEmilio Fumero, Felipe García, J M Gatell
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled studyCesar Fisac, Nuria Virgili, Elena Ferrer, et al.
AIDS (London, England)|May 21, 2005
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapineCesar Fisac, Emilio Fumero, Manuel Crespo, et al.
AIDS (London, England)|July 29, 2004
Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or lessElena Ferrer, Elena Santamariña, Pere Domingo, et al.
The Lancet. Microbe|May 11, 2022
Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case reportMaria C Puertas, George Ploumidis, Michalis Ploumidis, et al.
Frontiers in Microbiology|June 17, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut MicrobiotaInes B Moura, Ayman Grada, William Spittal, et al.
AIDS Research and Human Retroviruses|August 7, 2007
Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patientsPedro Castro, Montserrat Laguno, Meritxell Nomdedeu, et al.
The Journal of Infectious Diseases|October 24, 2007
Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activationAnna Suy, Pedro Castro, Meritxell Nomdedeu, et al.
The Journal of Infectious Diseases|February 25, 2003
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapineElena Ferrer, Daniel Podzamczer, Mireia Arnedo, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Opinion in HIV and AIDS|April 18, 2009
Immune modulators and treatment interruptionFelipe García, Emilio Fumero, José María Gatell
The Journal of Antimicrobial Chemotherapy|February 14, 2004
Immunosuppressive drugs as an adjuvant to HIV treatmentEmilio Fumero, Felipe García, J M Gatell
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled studyCesar Fisac, Nuria Virgili, Elena Ferrer, et al.
AIDS (London, England)|May 21, 2005
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapineCesar Fisac, Emilio Fumero, Manuel Crespo, et al.
AIDS (London, England)|July 29, 2004
Nevirapine-containing regimens in HIV-infected naive patients with CD4 cell counts of 200 cells/microl or lessElena Ferrer, Elena Santamariña, Pere Domingo, et al.
The Lancet. Microbe|May 11, 2022
Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case reportMaria C Puertas, George Ploumidis, Michalis Ploumidis, et al.
Frontiers in Microbiology|June 17, 2022
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut MicrobiotaInes B Moura, Ayman Grada, William Spittal, et al.
AIDS Research and Human Retroviruses|August 7, 2007
Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patientsPedro Castro, Montserrat Laguno, Meritxell Nomdedeu, et al.
The Journal of Infectious Diseases|October 24, 2007
Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activationAnna Suy, Pedro Castro, Meritxell Nomdedeu, et al.
The Journal of Infectious Diseases|February 25, 2003
Genotype and phenotype at baseline and at failure in human immunodeficiency virus-infected antiretroviral-naive patients in a randomized trial comparing zidovudine and lamivudine plus nelfinavir or nevirapineElena Ferrer, Daniel Podzamczer, Mireia Arnedo, et al.
Pageof 3